• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童肾性骨营养不良治疗的最新进展

Recent advances in the management of renal osteodystrophy in children.

作者信息

Salusky I B, Ramirez J A, Goodman W G

机构信息

University of California at Los Angeles School of Medicine.

出版信息

Curr Opin Nephrol Hypertens. 1993 Jul;2(4):580-7. doi: 10.1097/00041552-199307000-00008.

DOI:10.1097/00041552-199307000-00008
PMID:7859020
Abstract

Secondary hyperparathyroidism remains the predominant histologic lesion in pediatric patients undergoing regular dialysis, but recent evidence indicates that the regulation of parathyroid hormone secretion by calcium does not differ substantially between patients with osteitis fibrosa and subjects with normal renal function. Growth retardation and skeletal deformities are major findings in pediatric patients with renal osteodystrophy, and alterations in vitamin D metabolism and insulin-like growth factor almost certainly contribute to these findings. Avoidance of aluminum-containing medications and the introduction of intermittent calcitriol therapy provide newer approaches to the effective management of secondary hyperparathyroidism in pediatric patients with end-stage renal disease.

摘要

继发性甲状旁腺功能亢进仍然是接受常规透析的儿科患者主要的组织学病变,但最近的证据表明,纤维性骨炎患者与肾功能正常者相比,钙对甲状旁腺激素分泌的调节并无显著差异。生长发育迟缓与骨骼畸形是患有肾性骨营养不良的儿科患者的主要表现,维生素D代谢及胰岛素样生长因子的改变几乎肯定与这些表现有关。避免使用含铝药物以及采用间歇性骨化三醇疗法为有效治疗终末期肾病儿科患者的继发性甲状旁腺功能亢进提供了新方法。

相似文献

1
Recent advances in the management of renal osteodystrophy in children.儿童肾性骨营养不良治疗的最新进展
Curr Opin Nephrol Hypertens. 1993 Jul;2(4):580-7. doi: 10.1097/00041552-199307000-00008.
2
Prevention and treatment of renal osteodystrophy in children with chronic renal insufficiency and end-stage renal disease.
Semin Nephrol. 2001 Sep;21(5):441-50. doi: 10.1053/snep.2001.24938.
3
Evolution of secondary hyperparathyroidism during oral calcitriol therapy in pediatric renal osteodystrophy.小儿肾性骨营养不良患者口服骨化三醇治疗期间继发性甲状旁腺功能亢进的演变
Contrib Nephrol. 1991;90:189-95. doi: 10.1159/000420142.
4
Management of bone disease in the dialysis patient.
Blood Purif. 1985;3(1-3):27-41. doi: 10.1159/000169396.
5
Renal osteodystrophy.肾性骨营养不良
Curr Opin Pediatr. 1998 Apr;10(2):190-6. doi: 10.1097/00008480-199804000-00013.
6
Update on renal osteodystrophy: pathogenesis and clinical management.
Am J Med Sci. 1999 Apr;317(4):251-60. doi: 10.1097/00000441-199904000-00008.
7
Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.间歇性骨化三醇治疗后继发性甲状旁腺功能亢进患者动力缺失性骨病的发展
Kidney Int. 1994 Oct;46(4):1160-6. doi: 10.1038/ki.1994.380.
8
[Renal osteodystrophy].肾性骨营养不良
Ned Tijdschr Geneeskd. 1991 Jul 6;135(27):1213-7.
9
Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD.接受持续性非卧床腹膜透析(CAPD)或持续性循环腹膜透析(CCPD)的儿科透析患者的骨病
Kidney Int. 1988 May;33(5):975-82. doi: 10.1038/ki.1988.96.
10
The role of phosphate and other factors on the pathogenesis of renal osteodystrophy.磷酸盐及其他因素在肾性骨营养不良发病机制中的作用。
Adv Exp Med Biol. 1977;81:467-75. doi: 10.1007/978-1-4613-4217-5_47.

引用本文的文献

1
Metabolism and Endocrine Disorders: What Wnt Wrong?代谢和内分泌紊乱:Wnt 出了什么问题?
Front Endocrinol (Lausanne). 2022 May 6;13:887037. doi: 10.3389/fendo.2022.887037. eCollection 2022.